145 related articles for article (PubMed ID: 36575861)
1. A novel cDNA-uPA/SCID/Rag2
Uchida T; Teraoka Y; Imamura M; Abe-Chayama H; Makokha GN; Hayes CN; Aikata H; Hamamura S; Ishida Y; Tateno C; Shirouzu T; Kawai S; Tanaka Y; Ohdan H; Okada S; Chayama K
J Viral Hepat; 2023 Mar; 30(3):262-272. PubMed ID: 36575861
[TBL] [Abstract][Full Text] [Related]
2. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.
Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K
Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology.
Uchida T; Imamura M; Kan H; Hiraga N; Hayes CN; Tsuge M; Abe-Chayama H; Aikata H; Makokha GN; Miki D; Ochi H; Ishida Y; Tateno C; Chayama K
J Gen Virol; 2017 May; 98(5):1040-1047. PubMed ID: 28141486
[TBL] [Abstract][Full Text] [Related]
4. Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA/SCID Mice.
Tateno C; Kawase Y; Tobita Y; Hamamura S; Ohshita H; Yokomichi H; Sanada H; Kakuni M; Shiota A; Kojima Y; Ishida Y; Shitara H; Wada NA; Tateishi H; Sudoh M; Nagatsuka S; Jishage K; Kohara M
PLoS One; 2015; 10(11):e0142145. PubMed ID: 26536627
[TBL] [Abstract][Full Text] [Related]
5. Chimeric mouse model for the infection of hepatitis B and C viruses.
Tesfaye A; Stift J; Maric D; Cui Q; Dienes HP; Feinstone SM
PLoS One; 2013; 8(10):e77298. PubMed ID: 24155939
[TBL] [Abstract][Full Text] [Related]
6. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.
Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G
J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528
[TBL] [Abstract][Full Text] [Related]
7. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.
Meuleman P; Libbrecht L; De Vos R; de Hemptinne B; Gevaert K; Vandekerckhove J; Roskams T; Leroux-Roels G
Hepatology; 2005 Apr; 41(4):847-56. PubMed ID: 15791625
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease.
Douglas DN; Kawahara T; Sis B; Bond D; Fischer KP; Tyrrell DL; Lewis JT; Kneteman NM
PLoS One; 2010 Feb; 5(2):e9209. PubMed ID: 20174638
[TBL] [Abstract][Full Text] [Related]
9. Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver.
Ohshita H; Tateno C
Methods Mol Biol; 2017; 1506():91-100. PubMed ID: 27830547
[TBL] [Abstract][Full Text] [Related]
10. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
Vanwolleghem T; Meuleman P; Libbrecht L; Roskams T; De Vos R; Leroux-Roels G
Gastroenterology; 2007 Oct; 133(4):1144-55. PubMed ID: 17919490
[TBL] [Abstract][Full Text] [Related]
11. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
Meuleman P; Leroux-Roels G
Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
[TBL] [Abstract][Full Text] [Related]
12. Mice with Chimeric Human Livers and Their Applications.
Douglas DN; Kneteman NM
Methods Mol Biol; 2019; 1911():459-479. PubMed ID: 30593646
[TBL] [Abstract][Full Text] [Related]
13. Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.
Dusséaux M; Masse-Ranson G; Darche S; Ahodantin J; Li Y; Fiquet O; Beaumont E; Moreau P; Rivière L; Neuveut C; Soussan P; Roingeard P; Kremsdorf D; Di Santo JP; Strick-Marchand H
Gastroenterology; 2017 Dec; 153(6):1647-1661.e9. PubMed ID: 28851562
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
15. A novel animal model for in vivo study of liver cancer metastasis.
Fujiwara S; Fujioka H; Tateno C; Taniguchi K; Ito M; Ohishi H; Utoh R; Ishibashi H; Kanematsu T; Yoshizato K
World J Gastroenterol; 2012 Aug; 18(29):3875-82. PubMed ID: 22876040
[TBL] [Abstract][Full Text] [Related]
16. Development of humanized mice for the study of hepatitis C virus infection.
Turrini P; Sasso R; Germoni S; Marcucci I; Celluci A; Di Marco A; Marra E; Paonessa G; Eutropi A; Laufer R; Migliaccio G; Padron J
Transplant Proc; 2006 May; 38(4):1181-4. PubMed ID: 16757300
[TBL] [Abstract][Full Text] [Related]
17. Liver immune-pathogenesis and therapy of human liver tropic virus infection in humanized mouse models.
Bility MT; Li F; Cheng L; Su L
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1(0 1):120-4. PubMed ID: 23855307
[TBL] [Abstract][Full Text] [Related]
18. A mouse model of inducible liver injury caused by tet-on regulated urokinase for studies of hepatocyte transplantation.
Song X; Guo Y; Duo S; Che J; Wu C; Ochiya T; Ding M; Deng H
Am J Pathol; 2009 Nov; 175(5):1975-83. PubMed ID: 19808649
[TBL] [Abstract][Full Text] [Related]
19. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
[TBL] [Abstract][Full Text] [Related]
20. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection.
Meuleman P; Steyaert S; Libbrecht L; Couvent S; Van Houtte F; Clinckspoor F; de Hemptinne B; Roskams T; Vanlandschoot P; Leroux-Roels G
Clin Chim Acta; 2006 Apr; 366(1-2):156-62. PubMed ID: 16253217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
